effects [qlco]
Raloxifene [orch, phsu]
Serum lipids NOS [lbpr]
Coagulation Factors [aapp, bacs, phsu]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Context [fndg]
Raloxifene [orch, phsu]
Selective Estrogen Receptor Modulator [horm, phsu]
Estrogen Effects [fndg]
agonists [phsu]
Bone [bpoc]
Estrogen Effects [fndg]
Antagonist [ortf]
Breast [bpoc]
Uterus [bpoc]
Objective [inpr]
effects [qlco]
Raloxifene [orch, phsu]
Marker [clna]
CARDIOVASCULAR [bdsy]
Risk [qlco]
postmenopausal [tmco]
Women [popg]
To [qlco]
Compare [acty]
Induced [ftcn]
Hormone replacement therapy [topp]
Design [acty]
DOUBLE BLIND [resa]
randomized [resa]
Parallel [qlco]
Trial [resa]
setting [ftcn]
Eight [qnco]
Sites [spco]
United States [geoa]
participants [popg]
Health [idcn]
postmenopausal [tmco]
Women [popg]
advertisement [inpr]
intervention [hlca]
participants [popg]
randomized [resa]
To [qlco]
Receive [qlco]
Treatments [topp]
Raloxifene [orch, phsu]
mg/d [qnco]
Raloxifene [orch, phsu]
mg/d [qnco]
Hormone replacement therapy [topp]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg/d [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
mg/d [qnco]
placebo [topp]
Main [qlco]
Outcome Measures [qnco]
Change [ftcn]
Percent [qnco]
Change [ftcn]
baseline [bodm]
Lipid level [lbtr]
Coagulation [ortf]
Parameters [fndg]
months [tmco]
treatment [ftcn]
Result [ftcn]
Last [qlco]
Visit [bhvr]
COMPLETED [qlco]
Compared [acty]
placebo [topp]
Dosages [qnco]
Raloxifene [orch, phsu]
lowered [spco]
Low Density Lipoprotein Cholesterol [bacs, strd]
P NOS [aapp, imft]
Similar [qlco]
reduction [npop]
Hormone replacement therapy [topp]
P NOS [aapp, imft]
Dosages [qnco]
Raloxifene [orch, phsu]
lowered [spco]
Lipoprotein (a) [aapp, bacs]
P NOS [aapp, imft]
Decrease [qlco]
Hormone replacement therapy [topp]
P NOS [aapp, imft]
Raloxifene [orch, phsu]
Increased cholesterol [fndg]
P NOS [aapp, imft]
Increase [ftcn]
Hormone replacement therapy [topp]
P NOS [aapp, imft]
Raloxifene [orch, phsu]
Not [ftcn]
Change [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Hormone replacement therapy [topp]
Increased [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Decreased [qnco]
P NOS [aapp, imft]
Raloxifene [orch, phsu]
lowered [spco]
Fibrinogen [aapp, bacs, phsu]
P NOS [aapp, imft]
Hormone replacement therapy [topp]
Effect [qlco]
treatment [ftcn]
Changed [ftcn]
Fibrinopeptide A [aapp, bacs]
Conclusions [idcn]
Raloxifene [orch, phsu]
Altered [ftcn]
Markers, Biochemical [qlco]
CARDIOVASCULAR [bdsy]
Risk [qlco]
decreasing ldl [fndg]
Fibrinogen [aapp, bacs, phsu]
Lipoprotein (a) [aapp, bacs]
Increasing [ftcn]
Cholesterol [bacs, strd]
Triglycerides [bacs, lipd]
Hormone replacement therapy [topp]
Raloxifene [orch, phsu]
Effect [qlco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Lesser [qlco]
Effect [qlco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Lipoprotein (a) [aapp, bacs]
Further [spco]
Clinical Trials [resa]
Favorable [qlco]
Biochemical [ftcn]
Effect [qlco]
Associated [qlco]
Protection [fndg]
Cardiovascular disease [dsyn]
